Small-Molecule TKIs Boost HER2+ Breast Cancer Therapy
The landscape of HER2-positive breast cancer treatment continues to evolve rapidly, with researchers tirelessly seeking enhanced neoadjuvant therapies that can maximize tumor response before surgery while minimizing adverse effects. In a pivotal new systematic review and network meta-analysis published in BMC Cancer, investigators have cast a spotlight on the efficacy and safety profiles of small-molecule […]

What's Your Reaction?






